Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
Johnson & Johnson files for European approval of Ebola vaccine
Johnson & Johnson files for European approval of Ebola vaccine
Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
Reuters: Health
Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.
China's pork output to fall by at least 20% in 2019: FAO
China's pork output to fall by at least 20% in 2019: FAO
Reuters: Health
African swine fever (ASF) will cut pork output in China, the world's largest producer, by at least 20% in 2019, the United Nations' food agency said on Thursday, doubling the decline it had expected six months ago. 
Reuters: Health
African swine fever (ASF) will cut pork output in China, the world's largest producer, by at least 20% in 2019, the United Nations' food agency said on Thursday, doubling the decline it had expected six months ago.
Chinese government bodies call for prohibition on vaping in public
Chinese government bodies call for prohibition on vaping in public
Reuters: Health
Chinese government bodies have jointly called for a ban on consuming e-cigarettes in public, as the country gradually works to regulate its fast-growing vaping industry. 
Reuters: Health
Chinese government bodies have jointly called for a ban on consuming e-cigarettes in public, as the country gradually works to regulate its fast-growing vaping industry.
China's Bio-Thera gets approval for Humira biosimilar
China's Bio-Thera gets approval for Humira biosimilar
Reuters: Health
China's Bio-Thera Solutions Ltd has won a regulatory approval for its version of AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, paving the way for the first such biosimilar to enter the world's second-largest drug market. 
Reuters: Health
China's Bio-Thera Solutions Ltd has won a regulatory approval for its version of AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, paving the way for the first such biosimilar to enter the world's second-largest drug market.
ObsEva IVF nolasiban drug flops in key European trial
ObsEva IVF nolasiban drug flops in key European trial
Reuters: Health
Swiss-listed drugmaker ObsEva said on Thursday it is abandoning the current program for its drug prospect nolasiban after the agent aimed at boosting pregnancy following in-vitro fertilization (IVF) failed a late-stage study in Europe. 
Reuters: Health
Swiss-listed drugmaker ObsEva said on Thursday it is abandoning the current program for its drug prospect nolasiban after the agent aimed at boosting pregnancy following in-vitro fertilization (IVF) failed a late-stage study in Europe.
China's tobacco monopoly means big risks for e-cigarette startups
China's tobacco monopoly means big risks for e-cigarette startups
Reuters: Health
In a glass-walled laboratory, chemists puff on vaping devices as they test liquid nicotine flavors. Nearby, staffers with cartons of instant noodles on their desks tap away at laptops, messaging suppliers and customers. 
Reuters: Health
In a glass-walled laboratory, chemists puff on vaping devices as they test liquid nicotine flavors. Nearby, staffers with cartons of instant noodles on their desks tap away at laptops, messaging suppliers and customers.
Subscribe to:
Comments (Atom)